UK Denies Pfizer’s Bid To Clear Path For Biosimilar Bevacizumab

Broken_Arrow
Pfizer has failed to get an Arrow declaration from a UK court against patents sought by Roche for its Avastin bevacizumab brand • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin